Apellis Pharmaceuticals, Inc. SEC Filings

Filed On	Filing
05 Jun 2026	SCHEDULE 13G/A
26 May 2026	15-12G
15 May 2026	SCHEDULE 13G/A
15 May 2026	SCHEDULE 13G/A
14 May 2026	Form 4: Dunlop A. Sinclair, Director Disposed of 161,567 shares (Tender Offer) · Returned 20,311 shares to the issuer · Disposed of 102,826 Stock Option (right to buy) (Disposition to Issuer)
14 May 2026	Form 4: Chopas James George, VP/Chief Accounting Officer Disposed of 65,955 shares (Tender Offer) · Received 38,244 shares as a grant or award · Returned 76,650 shares to the issuer · 1 more
14 May 2026	Form 4: Dolsten Mikael, Director Disposed of 14,312 shares (Tender Offer) · Returned 14,312 shares to the issuer · Disposed of 24,135 Stock Option (right to buy) (Disposition to Issuer)
14 May 2026	Form 4: Meltzer Leslie, Chief Research and Development Disposed of 107,024 shares (Tender Offer) · Received 67,830 shares as a grant or award · Returned 174,854 shares to the issuer · 1 more
14 May 2026	Form 4: Fonteyne Paul R., Director Disposed of 30,666 shares (Tender Offer) · Returned 24,188 shares to the issuer · Disposed of 112,726 Stock Option (right to buy) (Disposition to Issuer)
14 May 2026	Form 4: Sullivan Timothy Eugene, Chief Financial Officer Disposed of 212,437 shares (Tender Offer) · Received 159,080 shares as a grant or award · Returned 270,413 shares to the issuer · 1 more
14 May 2026	Form 4: Machiels Alec, Director Disposed of 796,939 shares (Tender Offer) · Returned 20,311 shares to the issuer · Disposed of 242,300 Stock Option (right to buy) (Disposition to Issuer)
14 May 2026	Form 4: Deschatelets Pascal, Chief Scientific Officer Disposed of 1,177,222 shares (Tender Offer) · Received 90,040 shares as a grant or award · Returned 135,445 shares to the issuer · 1 more
14 May 2026	Form 4: Chan Gerald, Director Disposed of 25,666 shares (Tender Offer) · Returned 24,188 shares to the issuer · Disposed of 242,300 Stock Option (right to buy) (Disposition to Issuer)
14 May 2026	Form 4: Nicholson Nur, Chief Technical Officer Disposed of 116,338 shares (Tender Offer) · Received 133,364 shares as a grant or award · Returned 221,303 shares to the issuer · 1 more
14 May 2026	Form 4: Walbert Keli, Director Disposed of 17,051 shares (Tender Offer) · Returned 16,293 shares to the issuer · Disposed of 30,072 Stock Option (right to buy) (Disposition to Issuer)
14 May 2026	Form 4: DeLong Mark Jeffrey, Chief Business & Strat Officer Disposed of 114,591 shares (Tender Offer) · Received 115,165 shares as a grant or award · Returned 186,543 shares to the issuer · 1 more
14 May 2026	Form 4: O'Brien Stephanie Monaghan, Director Disposed of 31,416 shares (Tender Offer) · Returned 24,188 shares to the issuer · Disposed of 242,300 Stock Option (right to buy) (Disposition to Issuer)
14 May 2026	Form 4: Boucher Kelley, Chief People Officer Disposed of 127,804 shares (Tender Offer) · Received 45,219 shares as a grant or award · Returned 173,023 shares to the issuer · 1 more
14 May 2026	Form 4: Wheeler Craig A, Director Disposed of 24,444 shares (Tender Offer) · Returned 23,071 shares to the issuer · Disposed of 42,879 Stock Option (right to buy) (Disposition to Issuer)
14 May 2026	Form 4: Watson David O., General Counsel Disposed of 204,653 shares (Tender Offer) · Received 153,737 shares as a grant or award · Returned 267,033 shares to the issuer · 1 more

Comments